Skip to main content
 

Rithem Life Sciences

Rithem Life Sciences

At Rithem Life Sciences, our mission is to save lives. Sudden cardiac arrest leads six million deaths each year, 68 percent at home. CPR must be administered within two to four minutes, an impossible time-frame for emergency services to arrive. We have developed two at-home devices, the ResQR and the JoltzAED for safe, effective CPR and automated external defibrillation designed specifically for at-home use.

More News

  • Innovators’ Network member, Powerful Medical, Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

  • Sense Neuro Diagnostics secures $2M contract for brain hemorrhage detection technology

  • Innovators’ Network Member Noah Labs Selected for EIC Acclerator